Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 36, 2026)
Company announcement No. 46 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 36, 2026) Copenhagen, Denmark, September 7, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
How Shravan Parsi went from pharma labs to 4,400 apartment units in Texas real estate
Around 70% of ten-year-olds in low- and middle-income countries cannot read and understand a simple written text, the World Bank estimated after the pandemic, up from 57% in 2019, a deficit the bank prices at $21 trillion in lost lifetime earnings…
Ascendis Pharma A/S $ASND Shares Bought by Frazier Life Sciences Management L.P.
Frazier Life Sciences Management L.P. raised its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 68.9% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 225,155 shares of the…
Frazier Life Sciences Management L.P. Has $613.03 Million Stake in NewAmsterdam Pharma Company N.V. $NAMS
Frazier Life Sciences Management L.P. lifted its stake in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 6.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The…
Swiss labour market remains strong
This was stated by Jérôme Cosandey, head of the labour division at the State Secretariat for Economic Affairs (SECO), while commenting via teleconference on the unemployment figures (3% in August). The only significant increase was…
US India Space Co-Creation: Powering Future Human Discovery
US Ambassador Sergio Gor announced a new phase in US-India space relations, shifting from mere cooperation to 'co-creation,' promising joint ventures in design, funding, and the future of human discovery, including India's role in the Artemis…
PharmaMar: Expensive Multiples For Zepzelca's Growth (OTCMKTS:PHMMF)
Pharma Mar is increasingly reliant on Zepzelca, even though Yondelis gives them a smaller recurring-revenue base today. Their first-line maintenance uptake is helping US royalties, while Germany and Austria give PHMMF another interesting European…
Novartis Heart-Drug Flop Deepens Pipeline Setbacks, Hits Rivals
Novartis AG suffered a second trial disappointment within a week after the Swiss pharma group's potential blockbuster heart drug failed in a final-stage study. The drug, pelacarsen, did lower levels of lipoprotein(a), a largely genetic risk factor…
India should target 10 million international patients a year: Goyal
Commerce and Industry Minister Piyush Goyal on Monday called on India's pharmaceutical and healthcare industry to build globally competitive medical devices and scale up medical value tourism, setting a target of 10 million international patients a…
Futures Drop As Iran Hostilities Send Brent To 6 Week High Above $97
US stock futures slipped in cautious, low volume trading as the latest Middle East escalation pushed oil prices higher, lifting bond yields in Europe and Asia. As of 9:00am ET, S&P futures were down 0.2% with Nasdaq futures modestly in the red…
Spike in Irish GDP triggers growth upgrade for euro zone
The euro zone economy expanded by more than originally estimated in the second quarter on the back of a sharp upward revision in Irish GDP (gross domestic product), according to Eurostat. Euro zone GDP increased 0.6 per cent, up from a preliminary…
Seoul to host 19th Asia-Pacific Conference of German Business
The Korean-German Chamber of Commerce and Industry (KGCCI) said Monday it will co-host the 19th Asia-Pacific Conference of German Business in Seoul from Oct. 29-31. The conference, to be held at the Grand InterContinental Seoul Parnas, is expected…
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party?
Dow Jones53,045.60−0.34% Russell 20002,966.29−0.18% Dow Jones53,045.60−0.34% Russell 20002,966.29−0.18% Dow Jones53,045.60−0.34% Russell 20002,966.29−0.18% Dow Jones53,045.60−0.34% Russell…
AI-designed drug appears to turn back the body's biological clock in early trial
Nano Banana Pro prompted by THE DECODER Insilico Medicine used generative AI to develop rentosertib, a drug for the lung disease IPF. A new study shows the drug may also reverse markers of biological aging. Researchers ran six independent AI aging…
Crude surge, Fed rate fears drag Nifty lower
Equities extended their losing streak on Monday, weighed down by a sharp rise in crude oil prices amid renewed concerns over the Strait of Hormuz and growing fears of a Federal Reserve rate hike following stronger-than-expected US jobs data. The…
Receive a Daily briefing on Pharma Industry News
Get Started